Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Inflammation
Erschienen in: Inflammation 2/2016

01.12.2015 | ORIGINAL ARTICLE

Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation

verfasst von: Tian-hui Cao, Song-gen Jin, Dong-sheng Fei, Kai Kang, Lei Jiang, Zhi-yuan Lian, Shang-ha Pan, Ming-ran Zhao, Ming-yan Zhao

Erschienen in: Inflammation | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Artesunate, a derivative of artemisinin, has anti-inflammatory properties and exerts protective roles in sepsis. Heme oxygense-1 (HO-1) inhibits the inflammatory response through reduction of proinflammatory cytokines and leukocyte influx into tissues. The present study investigated the effects of artesunate on HO-1 and septic lung injury. Cecal ligation and puncture (CLP) was employed to induce septic lung injury. Mice pretreated with artesunate (AS) (15 mg/kg) exhibited decreased sepsis-induced mortality and lung injury and alleviated lung pathological changes and neutrophil infiltration. In addition, AS lowered the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the serum and bronchoalveolar lavage fluid (BALF) and inhibited cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase isoform (iNOS) expression and NF-κB activation in lung tissue. In addition, AS enhanced NF-E2-related factor-2 (Nrf2) activation and HO-1 expression and enzymatic activity in lung tissue. However, the protective effects of AS on sepsis-induced lung injury were eliminated by ZnPP IX, an HO-1 competitive inhibitor. Therefore, AS plays protective roles in septic lung injury related to the upregulation of HO-1. These findings suggest an effective and applicable treatment to sepsis-induced lung injury and provide new insights into the molecular mechanisms and actions of AS.
Literatur
1.
Vincent, J.L., and H.K. Atalan. 2008. Epidemiology of severe sepsis in the intensive care unit. British Journal of Hospital Medicine 69: 442–443.CrossRefPubMed
2.
Rubenfeld, G.D., E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, et al. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353: 1685–1693.CrossRefPubMed
3.
Ryter, S.W., and A.M. Choi. 2010. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Current Drug Targets 11: 1485–1494.CrossRefPubMed
4.
Luo, Y.P., L. Jiang, K. Kang, D.S. Fei, X.L. Meng, C.C. Nan, et al. 2014. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. International Immunopharmacology 20: 24–32.CrossRefPubMed
5.
Fei, D., X. Meng, K. Kang, C. Nan, M. Zhao, S. Pan, et al. 2012. Heme oxygenase-1 modulates thrombomodulin and activated protein C levels to attenuate lung injury in cecal ligation and puncture-induced acute lung injury mice. Experimental Lung Research 38: 173–182.CrossRefPubMed
6.
Gozzelino, R., V. Jeney, and M.P. Soares. 2010. Mechanisms of cell protection by heme oxygenase-1. Annual Review of Pharmacology and Toxicology 50: 323–354.CrossRefPubMed
7.
Motterlini, R., and R. Foresti. 2014. Heme oxygenase-1 as a target for drug discovery. Antioxidants & Redox Signaling 20: 1810–1826.CrossRef
8.
Wang, J., H. Zhou, J. Zheng, J. Cheng, W. Liu, G. Ding, et al. 2006. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release. Antimicrobial Agents and Chemotherapy 50: 2420–2427.CrossRefPubMedPubMedCentral
9.
Li, B., R. Zhang, J. Li, L. Zhang, G. Ding, P. Luo, et al. 2008. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation. International Immunopharmacology 8: 379–389.CrossRefPubMed
10.
Li, B., J. Li, X. Pan, G. Ding, H. Cao, W. Jiang, et al. 2010. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. International Immunopharmacology 10: 344–350.CrossRefPubMed
11.
Jiang, W., B. Li, X. Zheng, X. Liu, Y. Cen, J. Li, et al. 2011. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin. International Immunopharmacology 11: 1065–1073.CrossRefPubMed
12.
Li, B., M. Yu, X. Pan, C. Ren, W. Peng, X. Li, et al. 2014. Artesunate reduces serum lipopolysaccharide in cecal ligation/puncture mice via enhanced LPS internalization by macrophages through increased mRNA expression of scavenger receptors. International Journal of Molecular Sciences 15: 1143–1161.CrossRefPubMedPubMedCentral
13.
Fei, D., X. Meng, M. Zhao, K. Kang, G. Tan, S. Pan, et al. 2012. Enhanced induction of heme oxygenase-1 suppresses thrombus formation and affects the protein C system in sepsis. Translational Research 159: 99–109.CrossRefPubMed
14.
Li, X.H., X. Gong, L. Zhang, R. Jiang, H.Z. Li, M.J. Wu, et al. 2013. Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1. Mediators of Inflammation 2013: 354087.PubMedPubMedCentral
15.
Hasan, Z., K. Palani, M. Rahman, S. Zhang, I. Syk, B. Jeppsson, et al. 2012. Rho-kinase signaling regulates pulmonary infiltration of neutrophils in abdominal sepsis via attenuation of CXC chemokine formation and mac-1 expression on neutrophils. Shock 37: 282–288.CrossRefPubMed
16.
Singleton, K.D., and P.E. Wischmeyer. 2003. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. European Surgical Research Europaische Chirurgische Forschung Recherches Chirurgicales Europeennes 35: 486–491.CrossRefPubMed
17.
Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145–156.CrossRefPubMed
18.
Agouridakis, P., D. Kyriakou, M.G. Alexandrakis, A. Prekates, K. Perisinakis, N. Karkavitsas, et al. 2002. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respiratory Research 3: 25.CrossRefPubMedPubMedCentral
19.
Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K.J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. Journal of Immunology 165: 2950–2954.CrossRef
20.
Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, et al. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662–664.CrossRefPubMed
21.
Riedemann, N.C., T.A. Neff, R.F. Guo, K.D. Bernacki, I.J. Laudes, J.V. Sarma, et al. 2003. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. Journal of Immunology 170: 503–507.CrossRef
22.
Liu, Z., Y. Fan, Y. Wang, C. Han, Y. Pan, H. Huang, et al. 2008. Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice. FEBS Letters 582: 1643–1650.CrossRefPubMed
23.
Li, B., Y.M. Li, X. Li, B. Shi, M.Y. He, X.L. Zhu, et al. 2009. COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats. The Journal of Surgical Research 157: 43–47.CrossRefPubMed
24.
Hahn, E.L., H.H. Tai, L.K. He, and R.L. Gamelli. 1999. Burn injury with infection alters prostaglandin E2 synthesis and metabolism. The Journal of Trauma 47: 1052–1057. discussion 1057–9.CrossRefPubMed
25.
Futaki, N., S. Takahashi, T. Kitagawa, Y. Yamakawa, M. Tanaka, and S. Higuchi. 1997. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo. Inflammation Research 46: 496–502.CrossRefPubMed
26.
Reddy, R.C., G.H. Chen, K. Tateda, W.C. Tsai, S.M. Phare, P. Mancuso, et al. 2001. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. American Journal of Physiology. Lung Cellular and Molecular Physiology 281: L537–L543.PubMed
27.
Ejima, K., M.D. Layne, I.M. Carvajal, P.A. Kritek, R.M. Baron, Y.H. Chen, et al. 2003. Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. The FASEB Journal 17: 1325–1327.PubMed
28.
Ohara, M., T. Sawa, K. Kurahashi, J.P. Wiener-Kronish, V. Doshi, I. Kudoh, et al. 1998. Induction of cyclooxygenase-2 in alveolar macrophages after acid aspiration: selective cyclooxygenase-2 blockade reduces interleukin-6 production. Anesthesiology 88: 1014–1022.CrossRefPubMed
29.
Gust, R., J.K. Kozlowski, A.H. Stephenson, and D.P. Schuster. 1999. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 160: 1165–1170.CrossRefPubMed
30.
Li, C., P. Gui, X. He, and H. Yang. 2000. Actions of NO and INOS on endotoxin induced rat acute lung injury and effect of rhubarb on them. Journal of Traditional Chinese Medicine 20: 216–222.PubMed
31.
Shelton, J.L., L. Wang, G. Cepinskas, M. Sandig, J.A. Scott, M.L. North, et al. 2007. Inducible NO synthase (iNOS) in human neutrophils but not pulmonary microvascular endothelial cells (PMVEC) mediates septic protein leak in vitro. Microvascular Research 74: 23–31.CrossRefPubMed
32.
Ren, D., R. Sun, and S. Wang. 2006. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1-induced acute lung injury. Inflammation Research 55: 207–215.CrossRefPubMed
33.
Hesse, A.K., M. Dorger, C. Kupatt, and F. Krombach. 2004. Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury. Respiratory Research 5: 11.CrossRefPubMedPubMedCentral
34.
Kristof, A.S., P. Goldberg, V. Laubach, and S.N. Hussain. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 158: 1883–1889.CrossRefPubMed
35.
Shanley, T.P., B. Zhao, D.R. Macariola, A. Denenberg, A.L. Salzman, and P.A. Ward. 2002. Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Critical Care Medicine 30: 1960–1968.CrossRefPubMed
36.
Surh, Y.J., K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park, et al. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutation Research 480–481: 243–268.CrossRefPubMed
37.
Schwartz, M.D., E.E. Moore, F.A. Moore, R. Shenkar, P. Moine, J.B. Haenel, et al. 1996. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Critical Care Medicine 24: 1285–1292.CrossRefPubMed
38.
Arnalich, F., E. Garcia-Palomero, J. Lopez, M. Jimenez, R. Madero, J. Renart, et al. 2000. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infection and Immunity 68: 1942–1945.CrossRefPubMedPubMedCentral
39.
Moine P., R. McIntyre, M.D. Schwartz, D. Kaneko, R. Shenkar, Y. Le Tulzo, et al. 2000. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85–91.CrossRefPubMed
40.
Hualin, C., X. Wenli, L. Dapeng, L. Xijing, P. Xiuhua, and P. Qingfeng. 2012. The anti-inflammatory mechanism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages. Inflammation 35: 1087–1093.CrossRefPubMed
41.
Kang, J.W., and S.M. Lee. 2012. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. Journal of Pineal Research 53: 67–76.CrossRefPubMed
42.
Colville-Nash, P.R., S.S. Qureshi, D. Willis, and D.A. Willoughby. 1998. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. Journal of Immunology 161: 978–984.
Metadaten
Titel
Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation
verfasst von
Tian-hui Cao
Song-gen Jin
Dong-sheng Fei
Kai Kang
Lei Jiang
Zhi-yuan Lian
Shang-ha Pan
Ming-ran Zhao
Ming-yan Zhao
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0290-2

Weitere Artikel der Ausgabe 2/2016

Inflammation 2/2016 Zur Ausgabe

ORIGINAL ARTICLE

Echinocystic Acid Inhibits IL-1β-Induced COX-2 and iNOS Expression in Human Osteoarthritis Chondrocytes

ORIGINAL ARTICLE

BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1

ORIGINAL ARTICLE

Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells

ORIGINAL ARTICLE

Oridonin Inhibits Cell Proliferation and Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

ORIGINAL ARTICLE

Senegenin Ameliorate Acute Lung Injury Through Reduction of Oxidative Stress and Inhibition of Inflammation in Cecal Ligation and Puncture-Induced Sepsis Rats

ORIGINAL ARTICLE

Tenuigenin Prevents IL-1β-induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing PI3K/AKT/NF-κB Signaling Pathway

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

10.05.2024 Periphere arterielle Verschlusskrankheit Nachrichten

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise